Shiite Cleric Ponders Running to Succeed Iraqi PM

Iraqi Shiite cleric Qassem Taei.
Iraqi Shiite cleric Qassem Taei.
TT

Shiite Cleric Ponders Running to Succeed Iraqi PM

Iraqi Shiite cleric Qassem Taei.
Iraqi Shiite cleric Qassem Taei.

Iraqi Shiite cleric Qassem Taei announced that he is considering running for head of the Iraqi government to succeed the outgoing Prime Minister Adel Abdul Mahdi.

A statement released by Taei’s office said that the cleric “received many requests by the demonstrators to run for office, especially by demonstrators in the Dhi Qar governorate.”

Dhi Qar protesters demonstrated in support of the cleric with some voicing their confidence in his ability to pull the country out of its current crisis.

“Taie has a comprehensive program that includes eliminating corruption and bringing all the corrupt from 2003 to date to trial, no matter how influential they are,” the statement said, adding that although Taei has not yet decided his position on this nomination, he is studying the matter seriously.

Abdul Mahdi resigned in December following massive anti-government protests.

He is serving in a caretaker capacity until a new government is formed.

Deep differences remain between political forces and demonstrators over appointing the next prime minister.

Protesters insist on the departure and accountability of all political elites accused of corruption and waste of state funds and who have governed since the overthrow of Saddam Hussein's regime in 2003.



Siga Technologies to Supply Mpox Therapy in Morocco

The Mohammed VI Tower in Rabat. (AFP)
The Mohammed VI Tower in Rabat. (AFP)
TT

Siga Technologies to Supply Mpox Therapy in Morocco

The Mohammed VI Tower in Rabat. (AFP)
The Mohammed VI Tower in Rabat. (AFP)

Drugmaker Siga Technologies said on Tuesday it would supply its therapy for mpox in Morocco as part of a contract in response to a request from the country's health ministry for protection against any potential outbreak of the disease.

Although the antiviral therapy Tpoxx has been available in Africa through clinical trials and the World Health Organization's emergency use access protocol to deal with the current outbreak of mpox virus, this agreement marks Siga's first commercial sale of the therapy on the continent, Reuters reported.

The therapy is approved in the US and Canada for the treatment of smallpox and authorized in Europe and the UK for smallpox, mpox, cowpox and complications from vaccinia virus.

The Africa Centres for Disease Control and Prevention stated last month that the outbreak is not under control, after the WHO declared it a public health emergency of international concern in August upon identifying the new variant.

Two cases of the disease have been confirmed in Morocco this year, according to the WHO.